@article {8332, title = {Longitudinal patient-oriented outcomes in neuropathy: Importance of early detection and falls.}, journal = {Neurology}, volume = {85}, year = {2015}, month = {2015 Jul 07}, pages = {71-9}, publisher = {85}, abstract = {

OBJECTIVE: To evaluate longitudinal patient-oriented outcomes in peripheral neuropathy over a 14-year time period including time before and after diagnosis.

METHODS: The 1996-2007 Health and Retirement Study (HRS)-Medicare Claims linked database identified incident peripheral neuropathy cases (ICD-9 codes) in patients >=65 years. Using detailed demographic information from the HRS and Medicare claims, a propensity score method identified a matched control group without neuropathy. Patient-oriented outcomes, with an emphasis on self-reported falls, pain, and self-rated health (HRS interview), were determined before and after neuropathy diagnosis. Generalized estimating equations were used to assess differences in longitudinal outcomes between cases and controls.

RESULTS: We identified 953 peripheral neuropathy cases and 953 propensity-matched controls. The mean (SD) age was 77.4 (6.7) years for cases, 76.9 (6.6) years for controls, and 42.1\% had diabetes. Differences were detected in falls 3.0 years before neuropathy diagnosis (case vs control; 32\% vs 25\%, p = 0.008), 5.0 years for pain (36\% vs 27\%, p = 0.002), and 5.0 years for good to excellent self-rated health (61\% vs 74\%, p < 0.0001). Over time, the proportion of fallers increased more rapidly in neuropathy cases compared to controls (p = 0.002), but no differences in pain (p = 0.08) or self-rated health (p = 0.9) were observed.

CONCLUSIONS: In older persons, differences in falls, pain, and self-rated health can be detected 3-5 years prior to peripheral neuropathy diagnosis, but only falls deteriorates more rapidly over time in neuropathy cases compared to controls. Interventions to improve early peripheral neuropathy detection are needed, and future clinical trials should incorporate falls as a key patient-oriented outcome.

}, keywords = {Accidental Falls, Aged, Aged, 80 and over, Early Diagnosis, Female, Humans, International Classification of Diseases, Longitudinal Studies, Male, Medicare, Patient-Centered Care, Peripheral Nervous System Diseases, Treatment Outcome, United States}, issn = {1526-632X}, doi = {10.1212/WNL.0000000000001714}, author = {Brian C. Callaghan and Kevin Kerber and Kenneth M. Langa and Banerjee, Mousumi and Rodgers, Ann and Ryan J McCammon and James F. Burke and Eva L Feldman} } @article {8930, title = {Expenditures in the elderly with peripheral neuropathy: Where should we focus cost-control efforts?}, journal = {Neurology. Clinical Practice}, volume = {3}, year = {2013}, month = {2013 Oct}, pages = {421-430}, abstract = {

To optimize care in the evaluation of peripheral neuropathy, we sought to define which tests drive expenditures and the role of the provider type. We investigated test utilization and expenditures by provider type in those with incident neuropathy in a nationally representative elderly, Medicare population. Multivariable logistic regression was used to determine predictors of MRI and electrodiagnostic utilization. MRIs of the neuroaxis and electrodiagnostic tests accounted for 88\% of total expenditures. Mean and aggregate diagnostic expenditures were higher in those who saw a neurologist. Patients who saw a neurologist were more likely to receive an MRI and an electrodiagnostic test. MRIs and electrodiagnostic tests are the main contributors to expenditures in the evaluation of peripheral neuropathy, and should be the focus of future efficiency efforts.

}, keywords = {Medical Expenses, Medicare/Medicaid/Health Insurance, Older Adults, Peripheral Neuropathy}, issn = {2163-0402}, doi = {10.1212/CPJ.0b013e3182a78fb1}, author = {Brian C. Callaghan and James F. Burke and Rodgers, Ann and Ryan J McCammon and Kenneth M. Langa and Eva L Feldman and Kevin Kerber} }